Redpoint Investment Management Pty LTD Exact Sciences Corp Transaction History

Redpoint Investment Management Pty LTD

  • $684 Million
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022
BUY
$72.5 - $100.68 $96,860 - $134,508
1,336 Added 31.76%
5,542 $431,000
Q3 2021

Nov 12, 2021
SELL
$90.24 - $124.05 $44,037 - $60,536
-488 Reduced 10.4%
4,206 $401,000
Q2 2021

Aug 05, 2021
BUY
$93.66 - $139.27 $82,046 - $122,000
876 Added 22.94%
4,694 $584,000
Q4 2020

Jan 13, 2021
BUY
$99.61 - $142.12 $72,316 - $103,179
726 Added 23.48%
3,818 $506,000
Q3 2020

Oct 09, 2020
BUY
$72.92 - $102.01 $225,468 - $315,414
3,092 New
3,092 $315,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email